[Experience in the treatment of water-salt retentions in cirrhosis by the antialdosterone 11614 R.P].
D015065:17-Hydroxycorticosteroids / Q000008:administration & dosage; D000328:Adult; D000731:Androstanes / Q000008:administration & dosage*; D001201:Ascites / Q000188:drug therapy; D004231:Diuresis; D004487:Edema / Q000188:drug therapy; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists; D009318:Natriuresis; D011188:Potassium / Q000097:blood / Q000652:urine; D011422:Propionates / Q000008:administration & dosage; D012964:Sodium / Q000097:blood / Q000652:urine
D015065:17-Hydroxycorticosteroids; D000731:Androstanes; D000451:Mineralocorticoid Receptor Antagonists; D011422:Propionates; D005665:Furosemide; D012964:Sodium; D011188:Potassium
Une experience de traitement des retentions hydro-salines des cirrhotiques par l'antialdosterone 11614 R.